TRiNDS's Unattributed VC Round

TRiNDS raised a round of funding on December 19, 2016. Investors include CureDuchenne Ventures.

TRiNDS is a specialized contract research organization for neuromuscular diseases, with four main pillars of solutions in clinical operations, data management, biostatistics, and study measurements.…

Articles about TRiNDS's Unattributed VC Round: